Open Payments Expansion Act
In committee: it can still change before the session ends.
- Stage
- In committee
- Started in
- Senate
- Sponsors
- 2
- Latest action
- Sep 4, 2025
What it does
The Open Payments Expansion Act would require pharmaceutical and device manufacturers, as well as applicable group purchasing organizations, to publicly disclose payments made to patient advocacy organizations, including both direct and indirect transfers of value, starting March 31, 2027, and annually thereafter. These disclosures would include the name of the patient advocacy organization and the amount of each covered payment, submitted electronically to the Secretary of Health and Human Services. The bill amends the Social Security Act to expand existing transparency requirements under the Open Payments program to cover patient advocacy organizations, which are defined as tax-exempt…
No official summary is available here. This one was written by AI from the bill’s text.
Where it stands
Introduced (Done)
Committee (Current step)
Floor (Not started)
Law (Not started)
What moved
Who is involved
Sponsors
The lawmakers who put their names on it, lead sponsors first.
In the news
Reporting that may mention this subject. Possible matches are labeled.
Loading coverage…
Where it goes next
While a bill can still move, the questions are about people and money.